SELARSDI

USTEKINUMAB-AEKN · Teva Pharmaceuticals USA, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SELARSDI, covering 2024-04-16 to 2025-12-01. Get the full timeline:

Most recent: FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)